PR Newswire BiotechOriginal article
SIBIONICS und PharmaSens erkunden auf der EASD 2026 neue Horizonte für die automatisierte Insulinabgabe
ConferenceAutomated Insulin Delivery SystemPositive
AI Analysis
Summary
SiBionics and PharmaSens presented their automated insulin delivery system integrated with continuous measurement technology at the EASD 2026 conference, focusing on improved diabetes care management.
Importance:3/10
Sentiment:
0.30
diabetesautomated insulin deliverycontinuous glucose monitoringEASD 2026medical device
Read the original article
Published by PR Newswire Biotech on October 5, 2026 2:54 AM
